Endometrial Cancer Consortium - Clinical Trial
¿Cuál es el Propósito de este estudio?
The Endometrial Cancer Molecularly Targeted Therapy Consortium is a multi-institutional alliance that is developing a cancer data and tissue repository. The information in this repository will be used to better understand tumor alterations and cancer biomarkers that can help us develop new therapies and potentially improve survival outcomes for women with endometrial cancer.
cáncer de endometrio
¿Quién puede participar en el Estudio?
Adults ages 18+ who are diagnosed with any form of endometrial cancer or pre-invasive endometrial cancer at any stage.
For more information about this study, please contact the study team at sarah.linhart@duke.edu.
¿Qué Implica?
If you choose to join this repository, we will collect medical information related to your cancer treatment for as long as you allow us to do so.
Detalles del Estudio
